Editorial ArticleDrug Discovery & Development
Why bioassay validation is no longer the finish line for biologics
A validated bioassay that worked yesterday is not guaranteed to work tomorrow, and CRO Prolytix is urging the industry to rethink what ‘validated’ really means
